Synairgen Share Discussion Threads

[stampylong trader] 17/10/2020 19:49

The power of a name can do wonders - it markets itself, and travels far. Memes and slogans do a similar job - politics aside, it got Trump into power with MAGA. It also worked with Boris Let's Get Brexit done.

My history teacher once said that the Spitfire was a good name, The spitfire - the plane that spits fire!

I was once told that GSK don't invent drugs - they just buy them, and market and advertise the hell out of them. Why are there like 10 different boxes of Voltarol on the shelf? Why buy paracetamol at 50p when you can have PANADOL with OPTI ZORB for £2! Do not underestimate Brand power.

[oranolio] 17/10/2020 19:01

I don't have the expertise of some of the superb posters on here and the lse board but this seem like a very logical summary of what's about to happen.

If anyone is thinking we will watch another million plus die globally from covid-19 this winter while sng001 sits in a storage room gathering dust then they're really not thinking straight.

We're already with Clinigen/MAP and further news will follow.

Word of sng001 is spreading fast.


Back to the question why hasn't Richard done an interview in the last week?
I would say he is waiting for something else to land in the coming week and is going through the motions and the process to show us all he is following the guidelines/route of bringing a drug through phase 3 trials to a T but knows that big pharma's are about to land on his doorstep and I'd imagine he has already had significant interest.

The heavily oversubscribed £87 million placing was the Checkmate move imho.

[irpy] 17/10/2020 16:55

Not only is there a Phase 3 trial that is expected to lead to multi approvals enabling unfettered entries to the global market but also The Company are able to drip feed SNG001 in to the markets via the MAP.

Luvvly Jubbly!